Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × High-Energy Shock Waves × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Triple Negative Breast Neoplasms 1 Thyroid Cancer, Papillary 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Prostatic Neoplasms 1 Pleuropulmonary blastoma 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Hairy Cell 1 Ganglioneuroblastoma 1 Endometrial Neoplasms 1 Duodenal Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage III Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1 Agnosia 1 Adenocarcinoma, Follicular 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡